Endotoxin tolerance and cross-tolerance in mast cells involves TLR4, TLR2 and FcεR1 interactions and SOCS expression: Perspectives on immunomodulation in infectious and allergic diseases

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Saturnino, Saulo F ^a   Prado, Roberta O ^a   Cunha Melo, José R ^a   Andrade, Marcus V ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; ENDOTOXIN; FC EPSILON RECEPTOR 1; FC RECEPTOR; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN E RECEPTOR;

ALLERGIC DISEASE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL STIMULATION; CONTROLLED STUDY; CROSS TOLERANCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INCUBATION TIME; INFECTION; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DRUG POTENTIATION; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; SECRETION;

ANIMALS; CELLS, CULTURED; ENDOTOXINS; IMMUNOMODULATION; INTERLEUKIN-6; MAST CELLS; MICE; MICE, INBRED C57BL; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, IGE; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955477026     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-240     Document Type: Article

References (32)

1. Martin GS, Mannino DM, Eaton S, Moss M. The Epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139, 12700374.
2. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut J, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent J, . for the International Surviving Sepsis Campaign Guidelines Committee Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437, for the International Surviving Sepsis Campaign Guidelines Committee.
3. Thomas L. Germs. N Engl J Med 1972, 287:553-555. 10.1056/NEJM197209142871109, 5050429.
4. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891. 10.1038/nature01326, 12490963.
5. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 6:973-983.
6. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088. 10.1126/science.282.5396.2085, 9851930.
7. Beutler B. Inferences, questions and possibilities in Toll-like receptor signaling. Nature 2004, 430:257-263. 10.1038/nature02761, 15241424.
8. Echtenacher B, Männel DN, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381:75-77. 10.1038/381075a0, 8609992.
9. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6:135-142. 10.1038/ni1158, 15662442.
10. Saturnino SF, Andrade MV. Toll-Like Receptors, New Horizons in Sepsis. Curr Mol Med 2007, 7:522-531. 10.2174/156652407781387109, 17691966.
11. Nakano N, Nishiyama C, Kanada S, Niwa Y, Shimokawa N, Ushio H, Nishiyama M, Okumura K, Ogawa H. Survival from polymicrobial infections involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections. Blood 2007, 109:4846-4855. 10.1182/blood-2006-09-045641, 17289816.
12. Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, Clouthier DE, Yanagisawa MM, Tsai M, Galli SJ. Mast cells promote homeostasis by limiting endothelin-1-in duced toxicity. Nature 2004, 432:512-516. 10.1038/nature03085, 15543132.
13. Mallen-St Clair J, Pham CT, Villalta SA, Caughey GH, Wolters PJ. Mast cell dipeptidyl peptidase I mediates survival from sepsis. J Clin Invest 2004, 113:628-634. 338261, 14966572.
14. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 2001, 167:2250-2256.
15. Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, Moss M, Shanholtz C, Yates CR, Meduri GU, Shriver MD, Ingersoll R, Scott AF, Beaty TH, Moitra J, Ma SF, Ye SQ, Barnes KC, Garcia JG. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 2006, 34:487-495. 10.1165/rcmb.2005-0404OC, 2644210, 16399953.
16. Braun-Fahrländer C, Riedler J, Herz U, Eder W, Waser M, Grize L, Maisch S, Carr D, Gerlach F, Bufe A, Lauener RP, Schierl R, Renz H, Nowak D, von Mutius E, . Allergy and Endotoxin Study Team Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002, 347:869-877. 10.1056/NEJMoa020057, 12239255, Allergy and Endotoxin Study Team.
17. Yoshioka M, Fukuishi N, Iriguchi S, Ohsaki K, Yamanobe H, Inukai A, Kurihara D, Imajo N, Yasui Y, Matsui N, Tsujita T, Ishii A, Seya T, Takahama M, Akagi M. Lipoteichoic acid downregulates FceRI expression on human mast cells through Toll-like receptor 2. J Allergy Clin Immunol 2007, 120:452-461. 10.1016/j.jaci.2007.03.027, 17481719.
18. Qiao H, Andrade MV, Lisboa FA, Morgan K, Beaven MA. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006, 107:610-618. 10.1182/blood-2005-06-2271, 1895616, 16174756.
19. Paul B. Beeson and With the Technical Assistance of Elizabeth Roberts. Tolerance to bacterial pyrogens: I. Factors influencing its development. J Exp Med 1947, 86:29-38. 10.1084/jem.86.1.29, 2135744, 19871652.
20. Tkaczyk C, Beaven MA, Brachman SM, Metcalfe DD, Gilfillan AM. The phospholipase Cγ1-dependent pathway of FCεRI-mediated mast cells activation is regulated independently of phosphatidylinositol-3-Kinase. J Biol Chem 2003, 278:48474-48484. 10.1074/jbc.M301350200, 13129935.
21. Baetz A, Frey M, Heeg K, Dalpke AH. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J Biol Chem 2004, 279:54708-15. 10.1074/jbc.M410992200, 15491991.
22. Gordon JR, Galli SJ. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 1991, 174:103-107. 10.1084/jem.174.1.103, 2118884, 1829107.
23. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 2006, 10:233. 10.1186/cc5055, 1751079, 17044947.
24. Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence. Curr Opin Immunol 2007, 19:31-38. 10.1016/j.coi.2006.11.006, 17126541.
25. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005, 5:446-458. 10.1038/nri1630, 15928677.
26. Okumura S, Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, Saito H, Okayama Y. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcεRI. Blood 2003, 102:2547-2554. 10.1182/blood-2002-12-3929, 12855579.
27. de Vos AF, Pater JM, van den Pangaart PS, van't Veer C, van der Poll T. In vivo lipopolysaccharide exposure of human blood leukocytes induces cross-tolerance to multiple TLR ligands. J Immunol 2009, 183:533-542. 10.4049/jimmunol.0802189, 19542464.
28. Sly LM, Rauh MJ, Kalesnikoff J, Song CH, Kristal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 2004, 21:227-239. 10.1016/j.immuni.2004.07.010, 15308103.
29. Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Guerra FM, Rottapel R. Putting out the fire: coordinated supression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 2008, 224:265-283. 10.1111/j.1600-065X.2008.00659.x, 18759933.
30. Frobøse H, Rønn SG, Heding PE, Mendoza H, Cohen P, Mandrup-Poulsen T, Billestrup N. Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol Endocrinol 2006, 20:1587-1596. 10.1210/me.2005-0301, 16543409.
31. Yang YJ, Chen W, Carrigan SO, Chen WM, Roth K, Akiyama T, Inoue J, Marshall JS, Berman JN, Lin TJ. TRAF6 specifically contributes to FcepsilonRI-mediated cytokine production but not mast cells degranulation. J Biol Chem 2008, 283:32110-32118. 10.1074/jbc.M802610200, 18772140.
32. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008, 8:478-86. 10.1038/nri2327, 2855166, 18483499.